This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Cell Therapeutics Europe S.r.l., Consiglio Nazionale Delle Ricerche, Nanovactor S.r.l.. Active years: 2009-2015.
Company Filing History:
1 out of 2 
1 out of 325 
1 out of 1 Years Active: 2009-2015
Title: Paolo Gasco: Innovator in Retinal Degeneration and Nanoparticle Formulations
Introduction
Paolo Gasco is a notable inventor based in Turin, Italy. He has made significant contributions to the fields of retinal degeneration and nanoparticle formulations. With a total of 2 patents, his work focuses on innovative solutions for medical applications.
Latest Patents
Gasco's latest patents include groundbreaking methods for preventing and delaying inherited retinal degenerations. His first patent details the use of serine palmitoyl transferase inhibitors for this purpose, along with the compositions that contain them. The second patent involves the development of solid lipid nanoparticles of platinum compounds, particularly antitumor platinum complexes. This invention outlines a detailed process for creating these nanoparticles, which includes preparing microemulsions and dispersing them in aqueous mediums.
Career Highlights
Throughout his career, Paolo Gasco has worked with esteemed institutions such as the Università Degli Studi Di Milano and the Consiglio Nazionale Delle Ricerche. His research has contributed to advancements in both academic and practical applications in the medical field.
Collaborations
Gasco has collaborated with notable colleagues, including Riccardo Ghidoni and Enrica Strettoi. Their joint efforts have furthered research and development in their respective areas of expertise.
Conclusion
Paolo Gasco's innovative work in retinal degeneration and nanoparticle formulations showcases his commitment to advancing medical science. His contributions are significant and continue to impact the field positively.